MedPath

Diethylpropion Hydrochloride

Diethylpropion Hydrochloride Extended Release Tablets, 75 mg CIV Rx only

Approved
Approval ID

d6cde8cc-26ae-4087-8eac-b11192749cc5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 3, 2023

Manufacturers
FDA

Calvin Scott & Co., Inc.

DUNS: 073404626

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DIETHYLPROPION HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code17224-760
Application NumberANDA091680
Product Classification
M
Marketing Category
C73584
G
Generic Name
DIETHYLPROPION HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateMarch 3, 2023
FDA Product Classification

INGREDIENTS (7)

MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
CARBOMER HOMOPOLYMER TYPE AInactive
Code: F68VH75CJC
Classification: IACT
TARTARIC ACIDInactive
Code: W4888I119H
Classification: IACT
HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MM2/S)Inactive
Code: 6N003M473W
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
DIETHYLPROPION HYDROCHLORIDEActive
Quantity: 75 mg in 1 1
Code: 19V2PL39NG
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 3/3/2023

Package Labeling:17224-760-28

17224-760-28

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.